CORRESP 1 filename1.htm celz_corresp.htm

Creative Medical Technology Holdings, Inc.

211 E. Osborn Road

Phoenix, Arizona 85012

 

May 17, 2022

 

Via Edgar

 

Ms. Christine Westbrook

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C.  20549

 

 

Re:

Creative Medical Technology Holdings, Inc.

 

 

Registration Statement on Form S-3

 

 

Filed May 10, 2022

File No. 333-264824

 

Dear Ms. Westbrook:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Creative Medical Technology Holdings, Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement to 5:00 p.m. on May 19, 2022, or as soon thereafter as is practicable.

 

Please contact Zev M. Bomrind of Fox Rothschild LLP, counsel to the Company, at (212) 878-7951, as soon as the registration statement has been declared effective, or if you have any other questions or concerns regarding this matter.

 

 

Sincerely,

 

 

 

 

 

/s/ Timothy Warbington

 

 

Timothy Warbington

 

 

Chief Executive Officer